Improvement of the embryonic stem cell test endpoint analysis by use of field potential detection

October 2010
Journal of Toxicological Sciences;Oct2010, Vol. 35 Issue 5, p619
Academic Journal
No abstract available.


Related Articles

  • Relative Developmental Toxicity of Glycol Ether Alkoxy Acid Metabolites in the Embryonic Stem Cell Test as compared with the In Vivo Potency of their Parent Compounds. Esther de Jong; Jochem Louisse; Miriam Verwei; Bas J. Blaauboer; Johannes J. M. van de Sandt; Ruud A. Woutersen; Ivonne M. C. M. Rietjens; Aldert H. Piersma // Toxicological Sciences;Jul2009, Vol. 110 Issue 1, p117 

    The embryonic stem cell test (EST) has been proposed as an in vitro assay that might reduce animal experimentation in regulatory developmental toxicology. So far, evaluation of the EST was not performed using compounds within distinct chemical classes. Evaluation within a distinct class of...

  • Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A. Fujiwara, Masataka; Yan, Peishi; Otsuji, Tomomi G.; Narazaki, Genta; Uosaki, Hideki; Fukushima, Hiroyuki; Kuwahara, Koichiro; Harada, Masaki; Matsuda, Hiroyuki; Matsuoka, Satoshi; Okita, Keisuke; Takahashi, Kazutoshi; Nakagawa, Masato; Ikeda, Tadashi; Sakata, Ryuzo; Mummery, Christine L.; Nakatsuji, Norio; Yamanaka, Shinya; Nakao, Kazuwa; Yamashita, Jun K. // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Induced pluripotent stem cells (iPSCs) are novel stem cells derived from adult mouse and human tissues by reprogramming. Elucidation of mechanisms and exploration of efficient methods for their differentiation to functional cardiomyocytes are essential for developing cardiac cell models and...

  • Evaluation of Mouse Embryonic Stem Cells Plasticity Through Different Differentiation Protocols. Groza, loan; Emoke, Pall; Elen, Gocza; Olga, Soritau; Zsuzsanna, Lichner; Cenariu, M.; Tomuleasa, C. // Bulletin of the University of Agricultural Sciences & Veterinary;2010, Vol. 67 Issue 2, p96 

    The present study was designed to evaluate the plasticity of mouse embryonic stem cells (ESCs). Cardiac and neural differentiation of the mouse ESCs was initiated by embryoid bodies (EBs) formation in hanging drops and in suspension. After aggregation the were transferred to the suspension...

  • Icariin promotes expression of PGC-1α, PPARα, and NRF-1 during cardiomyocyte differentiation of murine embryonic stem cells in vitro. Ling Ding; Xing-Guang Liang; Dan-Yan Zhu; Yi-Jia Lou // Acta Pharmacologica Sinica;Oct2007, Vol. 28 Issue 10, p1541 

    Aim: To investigate the effect of icariin on the expression of peroxisome proliferator-activated receptor γ coactivator-1 alpha (PGC-1α), peroxisome proliferator-activated receptor alpha (PPARα), and nuclear respiratory factor 1 (NRF-1) on cardiomyocyte differentiation of murine...

  • Monitoring Developmental Toxicity in the Embryonic Stem Cell Test Using Differential Gene Expression of Differentiation-Related Genes. van Dartel, Dorien A. M.; Pennings, Jeroen L. A.; de la Fonteyne, Liset J. J.; van Herwijnen, Marcel H.; van Delft, Joost H.; van Schooten, Frederik J.; Piersma, Aldert H. // Toxicological Sciences;Jul2010, Vol. 116 Issue 1, p130 

    The embryonic stem cell test (EST) has been designed to predict developmental toxicity based upon compound-induced inhibition of embryonic stem cell (ESC) differentiation. The end point scoring, the test duration, and the definition of the predictivity and the applicability domain require...

  • Genetic basis for developmental toxicity due to statin intake using embryonic stem cell differentiation model. Jyoti, S.; Tandon, S. // Human & Experimental Toxicology;Oct2015, Vol. 34 Issue 10, p965 

    The in utero environment is a key factor controlling the fate of the growing embryo. The deleterious effects of statins during the fetal development are still not very well understood. Data from animal studies and retrospective studies performed in pregnant women give conflicting reports. In...

  • Transcriptomic Characterization of C57BL/6 Mouse Embryonic Stem Cell Differentiation and Its Modulation by Developmental Toxicants. Gao, Xiugong; Yourick, Jeffrey J.; Sprando, Robert L. // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    The Tox21 program calls for transforming toxicology testing from traditional in vivo tests to less expensive and higher throughput in vitro methods. In developmental toxicology, a spectrum of alternative methods including cell line based tests has been developed. In particular, embryonic stem...

  • Cardiac Applications for Human Pluripotent Stem Cells. Shiba, Yuji; Hauch, Kip D.; Laflamme, Michael A. // Current Pharmaceutical Design;8/21/2009, Vol. 15 Issue 24, p2791 

    Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) can self-renew indefinitely, while maintaining the capacity to differentiate into useful somatic cell types, including cardiomyocytes. As such, these stem cell types represent an essentially inexhaustible source of...

  • Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Melkoumian, Zara; Weber, Jennifer L.; Weber, David M.; Fadeev, Andrei G.; Zhou, Yue; Dolley-Sonneville, Paula; Yang, Jiwei; Qiu, Liqun; Priest, Catherine A.; Shogbon, Christopher; Martin, Arthur W.; Nelson, Jodelle; West, Peter; Beltzer, James P.; Pal, Santona; Brandenberger, Ralph // Nature Biotechnology;Jun2010, Vol. 28 Issue 6, p606 

    Human embryonic stem cells (hESCs) have two properties of interest for the development of cell therapies: self-renewal and the potential to differentiate into all major lineages of somatic cells in the human body. Widespread clinical application of hESC-derived cells will require culture methods...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics